The most common side effects are mild and may include pain or redness at the injection site, mild diarrhea, nausea, or a feeling of swelling all over the body
CHARMM36m: an improved force field for folded and intrinsically disordered proteins
Cycle Duration No established protocol Repeatable Single cycle Key Considerations CRITICAL: No human clinical trials have been conducted All dosing information is from preclinical animal studies only Oral bioavailability in humans is unknown and uncharacterized Not FDA-approved or regulated as a pharmaceutical Community-reported doses lack clinical validation Subscribe to unlock this content Get weekly peptide research summaries, new study alerts, and protocol updates free
not an approved human therapy
Specifications Purity: 99% (RP-HPLC, each component) Identity: MS-verified Form: Lyophilised powder, sealed vial Storage: 20 C, protected from light Manufacturer: Oxford Research Syndicate Ltd Batch / Lot: supplied on COA For in-vitro laboratory research use only
MIMIC-III mortality prediction details We first trained MixEHR on the ~39 K patients with single-admissions to learn the disease topics